BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8090
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
Licensing Agreements 17
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
Equity Offering 18
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
Debt Offering 22
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc – Key Competitors 25
BioRestorative Therapies Inc – Key Employees 26
BioRestorative Therapies Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 28
Jan 22, 2018: BioRestorative Therapies Appoints Adam D. Bergstein as Senior Vice President, Planning and Business Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc, Key Competitors 25
BioRestorative Therapies Inc, Key Employees 26
BioRestorative Therapies Inc, Subsidiaries 27

List of Figures
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wm Morrison Supermarkets PLC:企業のM&A・事業提携・投資動向
    Wm Morrison Supermarkets PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wm Morrison Supermarkets PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • ViaSat Inc:企業の戦略・SWOT・財務情報
    ViaSat Inc - Strategy, SWOT and Corporate Finance Report Summary ViaSat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • PT Hanjaya Mandala Sampoerna Tbk. (HMSP):企業の財務・戦略的SWOT分析
    PT Hanjaya Mandala Sampoerna Tbk. (HMSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Xhale Inc:製品パイプライン分析
    Summary Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessm …
  • Coesia S.p.A.:戦略・SWOT・企業財務分析
    Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Magnotta Winery Corporation:企業の戦略・SWOT・財務情報
    Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report Summary Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Eguana Technologies Inc. (EGT)-エネルギー分野:企業M&A・提携分析
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company. It designs, manufactures and supplies high performance power control solutions for grid interactive energy storage systems. The company’s power control solutions charge and discha …
  • Odakyu Electric Railway Co Ltd (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co Ltd (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Qatar Airways Group Q.C.S.C.
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • ET Solar Group Corporation:企業の戦略的SWOT分析
    ET Solar Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Fcmb Group Plc:企業の戦略・SWOT・財務分析
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Motiva Enterprises LLC:企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆